US Stocks
/
Puma Biotechnology Inc Share Price

Puma Biotechnology Inc Share Price

NASDAQ: PBYI | Small Cap
$9.98
+$0.17 (1.68%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Puma Biotechnology Inc Stock Performance

Open
$9.65
Prev. Close
$9.81
Circuit Range
N/A
Day Range
$9.47 - $9.99
Year Range
$4.58 - $10.09
Volume
23,095
Average Traded
$9.84

Puma Biotechnology Inc Share Price Today

As of 9 October 2026, Puma Biotechnology Inc's share price is $9.98. The stock opened at $9.65, compared to its previous close of $9.81. During today's trading session, Puma Biotechnology Inc's share price traded between $9.47 and $9.99, with an average price of $9.73. Over the past 52 weeks, the stock has recorded a high of $10.09 and a low of $4.58. In terms of performance, Puma Biotechnology Inc's share price has risen by 33.24% over the last six months and is up 95.69% on a year-on-year basis.

Puma Biotechnology Inc Share Price Chart

$9.47$9.99
L
Show Current Price
H

Puma Biotechnology Inc Stock Fundamentals & Key Indicators

Market Cap
$499.11M
PE Ratio (TTM)
18.95
Dividend Yield
0.00%
EPS (TTM)
$0.52
Revenue (TTM)
$228.37B
Return On Equity (TTM)
19.28%
Profit Margin
13.62%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-7.35%

Puma Biotechnology Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$54.48$75.45$44.81$56.50
Net Profit$8.84$13.44-$3.75$8.19
Net Profit Margin16.23%17.81%-8.37%14.50%
Income ChangeN/A52.04%-127.90%318.40%

Puma Biotechnology Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$228.03$235.64$230.47$228.37
Net Profit$0.00$21.59$30.28$31.11
Net Profit Margin0.00%9.16%13.14%13.62%
Income ChangeN/AN/A40.25%2.74%

About Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Puma Biotechnology Inc Historical Returns

MonthOpenCloseChange %
Oct 2026
$9.96
$9.99
+0.55%
Sep 2026
$9.18
$9.94
+7.52%
Aug 2026
$7.84
$9.24
+16.67%
Jul 2026
$8.08
$7.92
-2.22%
Jun 2026
$7.04
$8.10
+13.60%
May 2026
$7.37
$7.13
-4.81%
Apr 2026
$6.46
$7.49
+17.40%
Mar 2026
$5.58
$6.38
+12.23%
Feb 2026
$6.47
$5.68
-12.40%
Jan 2026
$5.81
$6.49
+9.08%
Dec 2025
$4.97
$5.95
+17.82%
Nov 2025
$5.05
$5.05
-0.98%

PBYI Share Price FAQs

What is Puma Biotechnology Inc share price today?

chevron-up
Puma Biotechnology Inc share price today is $9.98 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Puma Biotechnology Inc stock?

chevron-up
The 52 week high of Puma Biotechnology Inc stock is $10.09, while the 52 week low is $4.58 as of 9 Oct '26.

What is PBYI's market capitalisation today?

chevron-up
PBYI market capitalisation is $499.11M as of October 9, 2026, at 4:07 am IST.

What is PBYI's net income for the last quarter?

chevron-up
PBYI's net income for the last quarter is 8.19B USD.

What is the 5 year returns of PBYI?

chevron-up
The 5 year returns of PBYI is 95.69% as on 9 Oct '26.

What is the high & low stock price of PBYI today?

chevron-up
PBYI stock price hit a high of $9.99 and low of $9.47 as of 9 Oct '26.

Can I buy PBYI shares in India?

chevron-up
Yes. You can buy PBYI in India by opening an international trading account.